<ARTICLE>                     5
<LEGEND>
The Schedule Contains Summary Financial Information Extracted From
Balance Sheets and Statements of Income

<CIK>                         0000878616
<NAME>                        Human Pheromone Sciences, Inc.
<MULTIPLIER>                                   1

                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                             953,000
<SECURITIES>                                             0
<RECEIVABLES>                                    1,022,000
<ALLOWANCES>                                      (54,000)
<INVENTORY>                                        368,000
<CURRENT-ASSETS>                                 2,340,000
<PP&E>                                             708,000
<DEPRECIATION>                                   (689,000)
<TOTAL-ASSETS>                                   2,359,000
<CURRENT-LIABILITIES>                              350,000
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                      3,706,000
<COMMON>                                        17,667,000
<OTHER-SE>                                    (19,364,000)
<TOTAL-LIABILITY-AND-EQUITY>                     2,359,000
<SALES>                                          1,755,000
<TOTAL-REVENUES>                                 2,785,000
<CGS>                                              856,000
<TOTAL-COSTS>                                      856,000
<OTHER-EXPENSES>                                 2,349,000
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                  16,000
<INCOME-PRETAX>                                  (440,000)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                              (440,000)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                     (440,000)
<EPS-BASIC>                                         (0.13)
<EPS-DILUTED>                                       (0.13)